JEPI vs XBI
JPMorgan Equity Premium Income ETF vs SPDR S&P Biotech ETF
- • JEPI pays a higher dividend yield (7.93%).
Side-by-side metrics
| Metric | JEPI | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.35% | 0.35% |
Dividend yield Trailing 12-month yield. | 7.93% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $46.16B | $10.92B |
YTD return | 7.47% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.40 | 1.01 |
P/E ratio | 24.39 | — |
Last price | $58.17 | $156.41 |
Inception | — | — |
Issuer | JPMorgan | State Street |
JEPI top holdings
| MA | Mastercard Inc Class A | 1.96% |
| AAPL | Apple Inc | 1.94% |
| MSFT | Microsoft Corp | 1.94% |
| V | Visa Inc Class A | 1.86% |
| NEE | NextEra Energy Inc | 1.80% |
| JNJ | Johnson & Johnson | 1.80% |
| EOG | EOG Resources Inc | 1.78% |
| MMM | 3M Co | 1.78% |
| JIMXX | JPMorgan Prime Money Market IM | 1.76% |
| ABBV | AbbVie Inc | 1.76% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About JEPI
JEPI (JPMorgan Equity Premium Income ETF) is Active equity income with covered-call overlay. Managed by JPMorgan, the fund carries $46.2B in assets under management, an expense ratio of 0.35%, a dividend yield of 7.93%. Its largest holding is Mastercard Inc Class A (MA), which represents 2.0% of the portfolio. Real Estate is the fund's largest sector exposure at 2.3%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.